chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Muscle weakeness; Testicular pain; Headache; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Muscle weakeness), TESTICULAR PAIN (Testicular pain), HEADACHE (Headache) and MYALGIA (Muscle pain) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     The patient's past medical history included CABG (History of CABG blood pressure medication, and history of damaged vocal chord with CABG procedure.). Concurrent medical conditions included Blood pressure high, Anxiety and Acid reflux (esophageal). Concomitant products included HYDROCODONE for Back discomfort, METOPROLOL for Blood pressure management, OMEPRAZOLE for GERD, ALBUTEROL [SALBUTAMOL], ACETYLSALICYLIC ACID (ASPIRIN 81), BUMETANIDE (BUMEX), BUMETANIDE, MULTIVITAMIN [VITAMINS NOS], ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]), THYROID and TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA) for an unknown indication.    On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced MUSCULAR WEAKNESS (Muscle weakeness), TESTICULAR PAIN (Testicular pain), HEADACHE (Headache) and MYALGIA (Muscle pain). At the time of the report, MUSCULAR WEAKNESS (Muscle weakeness), TESTICULAR PAIN (Testicular pain), HEADACHE (Headache) and MYALGIA (Muscle pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient after receiving the first dose of the vaccine experienced headache, muscle weakness, testicle pain, and muscle pain which has persisted up until today. The patient believed that the patient previously had Covid-19 in Nov-2019.   The patient's concomitant medications reported included Eye gel, 1 drop each eye 4 times a day, Isidolam, a low dose for anxiety, Cholesterol, (statin) 20mg tablet, Thyroid 15mg tablet. The patient also had Implant in their mouth.  No treatment information was provided.   This case was linked to MOD-2022-465664 (Patient Link).
Mom reported today that after he received his 15 month shots (DTaP + HIB), he had a high fever (over 103 -temp taken with an ear thermometer). She thought he had diarrhea, also, but not real sure. The fever broke on the 3rd day. He also had a small knot at site of injection. Mom reported this to us today 06/10/2003
Fainted; Fainted/aggravated it; chills; fever; Headache; body aches; All night woke up with sweats and burning; All night woke up with sweats and burning; All night woke up with sweats and burning; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received the second dose of bnt162b2 (Lot/batch number and Expiration date were not provided), via an unspecified route of administration in left arm on 20Feb2021 08:30 at single dose for covid-19 immunization. Medical history included Vasovagal synchope, allergy to Sulfa drugs. Concomitant medication included venlafaxine hydrochloride (EFFEXOR), metoprolol. The patient previously allergy to cipro and levaquin. The patient previously received the first dose of bnt162b2 (Lot number unknown), at the age of 45-year-old, via an unspecified route of administration in left arm on 28Jan2021 15:30 at single dose for covid-19 immunization. About 11 hours after 2nd dose (20Feb2021 19: 30), the patient got extreme chills and fever, headache and body aches. All night woke up with sweats and burning. Fainted around 21Feb2021 06:00 (patient had vasovagal synchope so maybe aggravated it). No treatment received. The patient was no pregnant. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
Achy pain left shoulder and upper arm radiating over left chest and down left arm. Sought care at local health center. Prescribed Vioxx x3days. Has slowly improved. Began course of Celebrex on approximately May 6. Also received massage therapy to the area. Additional information received 8/27/02 indicated that chest and arm pain has resolved. Information received 12/17/02, no change in shoulder discomfort.
SOB 3 mins after vaccine Denies chest pain, nausea, swelling , rash, itchy eyes. Patient describes it as if he went for air. Patient given water. v/s 136/76, 72,98% o2 RA, Alert and oriented x4. Patient felt s/s resolve after given water. 126/75
1st dose on 1/16/2021 Hives at the vax site about the size of 1 american quarter size , itching started on 1/25/21 night at 11:30 pm morning of 1/26/21 , itching less, but the hives are still present, red in color
On 5-11-19 states hurt a lot, sore immediately then started w/chills, hurts to move arm, this am pain on right side up to neck and hard to breathe, started sweating, pain persisting can't lift left arm, 2 naproxen 8:30 AM no help, no redness. On PE decreased aeration right base, no wheeze, no rales, points to right side of rib cage, pain worsens w/taking deep breaths, softball size left upper arm tender to touch, hurts to lift, no adenopathy, no redness, right arm mild tender no redness. Sent to ER to  r/o PE and OB U/S showed >14 weeks.
I had a breakthrough Case of Covid-19 I had a cough that proceeded to worse after dose 5, I had trouble breathing, with chest pain and weasing. I was prescribed antibiotics
Fever, severe headache, body aches, prolonged raised heart rate, fatigue, insomnia.  Symptoms lasted for 3 days.
About 10 p.m. I started with bad chills, nauseau, and fever.  Felt like I couldn't move at all.   Then developed bad headache -- couldn't get out of bed for about 12 hours -- almost went to the hospital I felt so bad.  Didn't have any breathing issues -- just severe flu symptoms.
A 25 year old male with no previous medical conditions, received the 2nd dose of anthrax on  04/07/99. In 07/99, the patient began experiencing a weakening of the eye muscle on the left eye. It was harder to focus, his vision worsened and eyeglasses were required. the patient experienced constant head pain in 08/99 while in Egypt, but the severity was sporadic. The patient received the 3rd dose of anthrax vaccine on 12/12/99 and the 4th dose of Anthrax vaccine on 01/16/00. In 02/00, the patient experienced acid reflux that is still ongoing which was treated with Nexium. The patient experienced itchy fluid-filled bumps on the back of his legs behind the knees in 10/00 that lasted  for several weeks and improved with cortisone cream treatment At the same time, the patient experienced generalized itchness and pruitus ani which are still ongoing and being treated with cortisone and antifungal cream which helps. In 08/01, the patient began to experience occasional muscle and joint pain in the legs and shoulder area. The patient was diagnosed with an Ingurial hernia in 09/01 for which he understands surgical repair. At the time of this report, the patient had not fully removed.
Pediatric 10 mcg dosage administered and was supposed to be 30 mcg.
Information has been received from a pharmacist concerning a patient who on an unspecified date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not reported). Subsequently the patient failed to developed proper titer. At the time of reporting the patient outcome was unknown. Additional information has been requested.
One day after receiving the vaccine, patient noted lower back pains, diffuse joint pains, fatigue, and gross hematuria. Symptoms persisted for 3 days but then resolved. Of note, Pt received first dose of Pfizer vaccine without incident.
Vomiting and nausea for 1 day and then the patient broke out in the varicella rash the following day.
Patient received Booster dose of Pfizer vaccine not knowing that they had previously received the first 2 doses (date of completion of 2 dose series 6/15/21) although booster is not approved for their age and patient is not immunocompromised
About 9 hours after the injection, I experienced chills, increased heart rate, and headache. I began taking alternate doses of aspirin and acetaminophen.  By 5 a.m., chills were gone.
This spontaneous report was received from registered nurse regarding a 21 year old female patient. The patient's medical history included dermatitis, hydrocodone allergy. The concurrent condition included allergic rhinitis and asthma. The patient was vaccinated with MMR II. Concomitant medications included drospirenone, YAZ, albuterol and CLODERM. The patient had previously received 2 doses of MMR II each on separate unspecified dates in the past. On 17-AUG-2012, the patient titre levels was performed and the patient was found to have low titre levels for measles, mumps and rubella,. No treatment information was reported. The outcome of the event was reported as not recovered (reported as "not changed"). Additional information has been requested.
1ST Shot, I hade muscle twitching in the L arm (vaccinated arm). 2ND Shot, I have extreme arm pain in R arm ( injected arm) Not only at injection site from radiating pain down arm. I had muscle twitching in injected arm again.  Headache, Fever 102.7 with chills and diaphoresis and body aches.
I have never suffered from headaches in my life - I had mild headache with the 1st dose; however, this second dose literally gave me migrane - now it is a cluster headache that I've had since February 5th, 2021 - the cluster headaches have not stopped - they are intolerable - I had to miss two days of work as a result - by the way the website gave me an error message when entering my age 52 years of age - it asked me for my age at time of vaccine and it tells me that it does not match their calculator
pt recv vax 5NOV96 & 8NOV96 pt devel fever of 102;no post vax rash noted;2JUN97 pt devel herpes zoster;
client began feeling feverish, chills and stomachache 4 days after receiving vaccine (May 25, 2019), contacted health office 4 days later (May 29, 2019) and was told by writer she should seek medical attention through primary care provider or urgent care if symptoms have not improved with treatment, client contacted by writer today (June 5, 2019) to follow up and client is currently admitted to the hospital for symptoms, has been in the hospital for one day,  was previously admitted on June 1st but sent home after a day, was re-admitted per pcp's instructions yesterday, client states she has "been feeling better, but not well enough to go home", will continue to follow up with client
Swelling size of my palm, hot to touch, very sore. Iced it, still hot
RECEIVED AN EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 30 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1805031, and expiry: 24-AUG-2021) dose was not reported, administered on 27-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 27-AUG-2021, the patient experienced received an expired vaccine. The action taken with covid-19 vaccine was not applicable. The outcome of received an expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20210931844, 20210931810, 20210932036, 20210932593, 20210932567, 20210931951, 20210932240, 20210932874 and 20210933076.
6/9/2023: headache, dizzy, fever, muscle soreness, redness 6/10/2023: redness, itchy, and feel burnt at the injection site 6/11/2023: redness expand larger than previous day, more frequently inchy and burnt
Approx 10 minutes after the immunization the patient started showing s/s of difficulty breathing and c/o itching. The patient was very flushed. Mouthed "I can't breathe". Wasn't able to speak a full sentence. Staff at the clinic first administered IM Benadryl out of the emergency bag, with Epinephrine on stand-by. About 2 minutes after the Benadryl was given, she started showing signs of breathing easier, and was starting to speak to staff. She said her doctor's office was across the street and he told her to go to his office if there was any reaction. She was able to walk out on her own, accompanied by her friend who was able to take her to her doctor's office.
ABSCESS RIGHT THIGH. PARENT TO APPLY WARM COMPRESSES THREE TIMES A DAY AND TO ADMINISTER AUGMENTIN 125MG TWICE A DAY FOR 10 DAYS. TO RETURN TO CLINIC ON FRIDAY 07/07/06 FOR RECHECK.
Soreness in left arm; severely swollen lymph nodes in left arm pit; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 27Oct2021 08:30 (Lot number:PfizerEW0217) at the age of 26 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU), administered in arm right, administration date 27Oct2021 as unk, single. The patient had no relevant medical history. Concomitant medication(s) included: MIRENA. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Pfizer EL3247, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM, Route of Administration: Intramuscular), administration date: 23Feb2021, when the patient was 26 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Pfizer EL3247, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM, Route of Administration: Intramuscular), administration date: 04Feb2021, when the patient was 26 years old, for Covid-19 immunization.  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 27Oct2021 18:00, outcome "recovered" (Oct2021), described as "Soreness in left arm"; LYMPHADENOPATHY (non-serious) with onset 27Oct2021 18:00, outcome "recovered" (Oct2021), described as "severely swollen lymph nodes in left arm pit". Therapeutic measures were not taken as a result of pain in extremity, lymphadenopathy. It was reported that prior to vaccination and since the vaccination the patient was not diagnosed with Covid 19.  No follow-up attempts are possible. No further information is expected.
I suffered from fatigue and I felt like I was having heart palpitations. They became acute, and they got worse. I became short of breath, with time I could barely move. The heart palpitations got worse, and that's when I went to the cardio at the hospital and I went to the entire process of the echo stress which I failed in 8 minutes. They found no blockages, and said it was electrical. I went to a special doctor that deals with that, and after several echoes and EP studies. He did the procedure, PVC abrasion process, with my arm to fix this and I felt fine since. And in February of this year, after the booster, I've had 2 episodes of A fib.
Information has been received from a doctor of pharmacy concerning an actually 22 year old female patient with no pertinent medical history and no drug reactions or allergies, who in November 2010 (also reported as December 2010), was vaccinated with the first dose of GARDASIL (lot number not reported). There was no concomitant medication. The doctor of pharmacy reported that within 10 days after receiving  her first dose, the patient developed a yeast infection and had to get a 7 day course of treatment with fluconazole. The first course of treatment began on 03-DEC-2010. During the time she had completed the GARDASIL series, she had 4 courses of treatment with fluconazole 02-DEC-2010, 14-MAR-2011, 28-MAR-2011 and 07-JUN-2011. It appeared that after each dose of GARDASIL the patient developed a yeast infection within 5 to 10 days, as well as additional episodes of infection. The patient sought unspecified medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.
pt recvd vax; lab tests revealed pt anti-HBc pos; pt felt that pos core antibody was a result of vax;
Patient called on 7/24/2018. She reported that she had pain and swelling on her left arm, at the site of a SHINGRIX vaccine that was administered on 7/16/18. She went to the ER on her own accord. She said she was diagnosed with cellulitis and prescribed CEFTIN.
The reporter believes the shingles involved the eyes; developed shingles approximately 1 week after receiving the SHINGRIX vaccine; This serious case was reported by a consumer via call center representative and described the occurrence of ophthalmic herpes zoster in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced ophthalmic herpes zoster (Verbatim: The reporter believes the shingles involved the eyes) (serious criteria GSK medically significant) and shingles (Verbatim: developed shingles approximately 1 week after receiving the SHINGRIX vaccine). The outcome of the ophthalmic herpes zoster was not reported and the outcome of the shingles was unknown.   It was unknown if the reporter considered the ophthalmic herpes zoster and shingles to be related to Shingrix.     It was unknown if the company considered the ophthalmic herpes zoster and shingles to be related to Shingrix.   Additional Information: GSK Receipt Date: 09-NOV-2023 The reporter was an acquaintance of the patient.   The reporter stated that the patient developed shingles approximately 1 week after receiving the Shingrix vaccine.   The reporter believed the shingles involved the eyes. The reporter did not consent to follow-up. The case is linked with US2023155531, by same reporter.; Sender's Comments:  US-GSK-US2023155531:2 of 2 report
Pt had a TDAP (ADACEL) on 12/14/10 she had pain in her (Lt) arm that evening. When she woke up on 12/15/10 she had pain in neck, left side of back and it seems to be increasing with stiffness. 12/17/10 called us to report - suggest she call her doctor or go to urgent care center. Advised her to call us back to let us know what MD says. Told her to ask for nurse.
Patient received injection on Monday 5/14/2018; beginning Tuesday 5/15/2018 through Thursday 5/17/2018, patient reported flu-like symptoms, 100.4 degree F fever, chills, feeling drained and body aches.
This spontaneous report as received from a other health professional refers to a 12 year old patient with prophylaxis. On 23-AUG-2017 the patient was vaccinated with PEDVAXHIB for prophylaxis. Other suspect therapies included GARDASIL 9. On 23-AUG-2017, 1 day after onset of therapy the patient experienced wrong drug administered. On an unknown date the patient experienced no adverse event and product label confusion. Additional information has been requested. Sender's Comments: US-009507513-1708USA013207.
3 months after vaccine I started having intermittent epigastric pains. I was told to start omeprazole which did not help. I had an ultrasound and a CT scan. I am waiting to see a GI doctor scheduled for 11/1. Please note I do not believe this event and the vaccine are related. And I received  my 3rd booster 10/11/22
Extreme pain radiating from back across rib cage to front abdomen.  I went to the urgent care and they thought I might be coming down with shingles.  Prescribed a week of prednisone which helped.  After the course of prednisone, the pain returned.  Ended up getting 3 courses of prednisone and the pain was still there.  Never got shingles.  A different doctor order CT scans and took several weeks for insurance authorization.  Took ibuprofen for a week.  Pain eventually subsided before insurance authorizations for CT scans was received.  Haven't gone for the scans yet.  Pain is there but minimal.  I received my moderna shot 3 weeks post surgery for breast implant replacement.  My surgeon said I should report this to you,
his vision in his left eye is now minimal; his left eye watering uncontrollably; his left eye hurt really bad/His sight in his right eye hurts his left eye; It was very blurry and can't make out much; light hurts more than anything; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient. A 40-year-old male patient received BNT162b2 (COMIRNATY), on 30Dec2022 at 13:15 as dose 1, single (Lot number: Fr2587) at the age of 40 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Copd" (unspecified if ongoing); "Hepatitis C" (unspecified if ongoing); "rheumatoid arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VISION BLURRED (disability) with onset 30Dec2022, outcome "not recovered", described as "It was very blurry and can't make out much"; EYE PAIN (disability) with onset 30Dec2022, outcome "not recovered", described as "his left eye hurt really bad/His sight in his right eye hurts his left eye"; LACRIMATION INCREASED (disability) with onset 30Dec2022, outcome "not recovered", described as "his left eye watering uncontrollably"; VISUAL IMPAIRMENT (disability) with onset 30Dec2022, outcome "not recovered", described as "his vision in his left eye is now minimal"; PHOTOPHOBIA (disability) with onset 30Dec2022, outcome "not recovered", described as "light hurts more than anything". The events "his vision in his left eye is now minimal", "his left eye watering uncontrollably", "his left eye hurt really bad/his sight in his right eye hurts his left eye", "it was very blurry and can't make out much" and "light hurts more than anything" required emergency room visit. Therapeutic measures were not taken as a result of visual impairment, lacrimation increased, eye pain, vision blurred, photophobia. Clinical course details: 5 minutes after the shot was given, his left eye hurt really bad and watering uncontrollably, and has been like that since his vision in his left eye is now minimal. It was very blurry and can't make out much. He had a 20/20 vision prior to this and light hurts more than anything. His sight in his right eye hurts his left eye. The patient has no known allergies. The patient has not been test post vaccination for covid. The patient has not had covid prior to vaccination.
Developed bursitis, diagnosed by physician. Severe pain, significantly limitation of mobility, vomitting due to pain.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a female patient who received FLUARIX Quadrivalent (batch 5GC54, expiry date 21st May 2018. Previously administered products included influenza vaccine (add received on an unknown date and had no reaction with flu vaccines). On an unknown date, the patient received FLUARIX Quadrivalent. On an unknown date, less than a year after receiving FLUARIX Quadrivalent, the patient experienced injection site erythema, injection site induration, injection site itching and injection site swelling. On an unknown date. the outcome of the injection site erythema, injection site induration, injection site itching and injection site swelling were unknown. It was unknown if the reporter considered the injection site erythema, injection site induration, injection site itching and injection site swelling to be related to FLUARIX Quadrivalent. Additional details were reported as follows: This case was reported by a Registered Pharmacist. The age at vaccination was not reported. The patient experienced red, hard, swollen and very itchy area, about 3 inches in diameter around the injection site. The patient had not yet seen her physician, but would be going. This case was linked to case US2017GSK152337, as reported by same reporter.